Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Rexahn completes patient enrollment in cancer drug trial
The two-stage single arm open label study in combination with gemcitabine enrolled nearly 35 patients to study the overall survival rate. The study is said to have met
The two-stage single arm open label study in combination with gemcitabine enrolled nearly 35 patients to study the overall survival rate. The study is said to have met
The contracts for drug development, valued at $56.3m were awarded to Neumedicines, RxBio, the University of Arkansas for Medical Sciences of Little Rock, Araim Pharmaceuticals of Ossining and
As per the terms of the deal, Galderma will acquire substantially all of Graceway’s assets including inventory and intellectual property rights and will assume the majority of Graceway’s
Northera is indicated as a treatment of symptomatic neurogenic orthostatic hypotension (NOH) in patients with primary autonomic failure, dopamine beta hydroxylase deficiency and non-diabetic autonomic neuropathy. The NDA
The Phase 1 dose escalation portion of the trial aims to investigate a single injection of different HTI-501 formulations into dimpled lesions of the skin followed by a
The affiliates of J&J include McNEIL-PPC, McNEIL MMP, LLC, and Johnson & Johnson. Following the agreement, J&J will own the venture’s assets which comprise exclusive rights to market
Cue-Mare is used for the induction of estrous in spring transitional mares, which is particularly important to enable early breeding. Tri-Otic Ointment is a canine treatment for acute
The acquisition allows Sony to boost up its own research and development, particularly for Point of Care diagnostic equipment and also to commercialize these products. Micronics will become
Most recently, Kelly worked as the chief commercial officer for BioVex, and was responsible for leading the company’s commercial efforts. Prior to BioVex, Kelly was the founder and
The company claims FenuLife is a completely natural fenugreek fiber that can act as a prophylactic treatment for heartburn and reflux symptoms. In addition to the prophylactic function,